Quality indicators for the management of heart failure in vulnerable elders.
Fonarow
G C
GC
University of California, Los Angeles, Los Angeles, California, USA. gfonarow@medne.ucla.edu
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002303:Cardiac Output, Low / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D004077:Digoxin / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D016330:Frail Elderly; D006299:Health Services for the Aged / Q000592:standards*; D006801:Humans; D008487:Medical History Taking; D008991:Monitoring, Physiologic; D010043:Outcome and Process Assessment, Health Care / Q000592:standards*; D010353:Patient Education as Topic; D010808:Physical Examination; D013318:Stroke Volume / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D004077:Digoxin